Alogliptin (NESINA), a dipeptidyl peptidase IV (DPP-4) inhibitor, was approved by the FDA on January 25, 2013 to improve blood sugar control in adults with type 2 diabetes. This drug had been ...
Two widely prescribed drugs for type 2 diabetes—sulfonylureas and basal insulin—may increase the risk of severe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback